Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Spherix Inc (SPEX)

Spherix Inc (SPEX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,865
  • Shares Outstanding, K 4,825
  • Annual Sales, $ 10 K
  • Annual Income, $ -4,180 K
  • 60-Month Beta 0.04
  • Price/Sales 1,066.86
  • Price/Cash Flow N/A
  • Price/Book 0.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.25
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/17/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6500 +150.77%
on 03/05/20
5.5200 -70.47%
on 03/09/20
+0.6400 (+64.38%)
since 02/12/20
3-Month
0.6500 +150.77%
on 03/05/20
5.5200 -70.47%
on 03/09/20
+0.4600 (+39.35%)
since 12/12/19
52-Week
0.6500 +150.77%
on 03/05/20
5.5200 -70.47%
on 03/09/20
-1.8100 (-52.65%)
since 03/12/19

Most Recent Stories

More News
Shareholder Update on Treatment for Coronavirus Optioned by Spherix

Spherix Incorporated (Nasdaq: SPEX) today provided an update on the recently announced treatment for Coronavirus technology optioned by the Company.

SPEX : 1.6300 (-18.09%)
Treatment for Coronavirus Optioned by Spherix

Spherix Incorporated (Nasdaq: SPEX) today announced it has executed an exclusive option agreement ("Option") with the University of Maryland, Baltimore (UMB) for the technology set forth in Patent number...

SPEX : 1.6300 (-18.09%)
Spherix Incorporated Changing Name to AIkido Pharma Inc. to Reflect Increased Focus on Artificial Intelligence and Machine Learning in Drug Development

Spherix Incorporated (Nasdaq: SPEX) ("Spherix" or the "Company") today announced that on March 13, 2020, the Company will officially change its name to AIkido Pharma Inc. ("AIkido"). Effective at the...

SPEX : 1.6300 (-18.09%)
Global Market for Cancer Therapies Could Exceed US$220 Billion by 2025

Despite decades of research costing billions of dollars, a cure for cancer still remains elusive. This fact when juxtaposed with the epidemic spread of cancer will result in the disease emerging into the...

SPEX : 1.6300 (-18.09%)
INO : 16.94 (+10.21%)
MITO : 1.3500 (+0.75%)
PFE : 36.05 (+0.81%)
LLY : 150.26 (+0.97%)
OMER : 10.11 (+2.85%)
Spherix Moves Dividend Record Date to Friday, March 6, 2020

Spherix Incorporated (Nasdaq: SPEX) announced that, in light of the expected closing of its public offering tomorrow, March 5, 2020, the record date with respect to the Hoth dividend has been moved to...

SPEX : 1.6300 (-18.09%)
Spherix Executes Machine Learning Scientific Research Agreement

Spherix Incorporated (Nasdaq: SPEX) today announced it has executed a Scientific Research Agreement with The University of Texas Southwestern Medical Center with the goal of using machine learning to find...

SPEX : 1.6300 (-18.09%)
Spherix Attends Artificial Intelligence and Machine Learning Pharmaceutical Development Conference

Spherix Incorporated (Nasdaq: SPEX) today announced its attendance at the AI & ML Drug Discovery Summit. The AI-ML in Drug Development Summit is the only conference to bring together industry leaders,...

SPEX : 1.6300 (-18.09%)
Spherix Announces a Special Dividend Distribution

Spherix Incorporated (Nasdaq: SPEX) today announced that on February 21, 2020, a special committee of the Board of Directors of Spherix Incorporated ("Spherix") approved a distribution to Spherix stockholders...

SPEX : 1.6300 (-18.09%)
Spherix Issues Letter to Shareholders

Spherix Incorporated (NASDAQ: SPEX), a technology development company committed to the fostering of innovative ideas, today issued a letter to shareholders:

SPEX : 1.6300 (-18.09%)
Spherix Launches Newly Redesigned Website

Spherix Incorporated (Nasdaq: SPEX) today announced that it has redesigned the company's website (www.spherix.com) to illuminate the overall digital transformation and recently acquired anti-cancer therapeutics....

SPEX : 1.6300 (-18.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade SPEX with:

Business Summary

Spherix is a technology innovations company. The Company consists of aBiotechnology Division (BioSpherix), a Commercial Information Services Division (CISD), a Government Information Services Division (GISD), and an Information Technology Division (ITD). CISD, GISD and ITD are collectively referred...

See More

Key Turning Points

2nd Resistance Point 2.1600
1st Resistance Point 1.8900
Last Price 1.6300
1st Support Level 1.4700
2nd Support Level 1.3200

See More

52-Week High 5.5200
Fibonacci 61.8% 3.6600
Fibonacci 50% 3.0900
Fibonacci 38.2% 2.5100
Last Price 1.6300
52-Week Low 0.6500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar